These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pitressin toxicity in diabetes insipidus, and the therapeutic superiority of the nasal route for replacement therapy; report of a case. SMITH WW. Ohio State Med J; 1957 Nov; 53(11):1277-9. PubMed ID: 13477644 [No Abstract] [Full Text] [Related]
13. The combined effect of chlorpropamide and chlorothiazide upon the response to vasopressin (Pitressin) in rats with hereditary diabetes insipidus. Laycock JF, Lee J, Lewis AF. J Anat; 1972 Feb 15; 111(Pt 2):329. PubMed ID: 5039189 [No Abstract] [Full Text] [Related]
15. [Comparative study of adiuretin-SD (DDAVP) and pitressin tannate in diabetes insipidus]. László C, János J, Ferenc L. Orv Hetil; 1977 Jul 10; 118(28):1648-50. PubMed ID: 876650 [No Abstract] [Full Text] [Related]
16. DIABETES INSIPIDUS. TREATMENT WITH 8-LYSINE VASOPRESSIN IN A NASAL SPRAY. CHIRMAN SB, KINSELL LW. Calif Med; 1964 Jul 10; 101(1):1-3. PubMed ID: 14179526 [Abstract] [Full Text] [Related]
17. Concentrating power of the kidney after five years of pitressin-tannate therapy in a patient with diabetes insipidus untreated for 13 years. (Investigations during intravenous administration of hypertonic sodium chloride, lysine-vasopressin, clopamide and furosemide). Radó JP, Marosi J, Takó J. Endokrinologie; 1970 Jul 10; 55(5):359-65. PubMed ID: 5439569 [No Abstract] [Full Text] [Related]